What is he best known for?
The fields of study he is best known for:
- Bacteria
- Gene
- Internal medicine
His primary areas of study are Microbiology, Legionella pneumophila, Typing, Bordetella pertussis and Serotype.
His Microbiology research is multidisciplinary, incorporating perspectives in Antiserum, Enterobacteriaceae, Escherichia coli, Agar and Genotype.
In his study, which falls under the umbrella issue of Legionella pneumophila, Effector is strongly linked to Gene.
The concepts of his Typing study are interwoven with issues in Infectious disease, Pathology, Clinical microbiology, Medical physics and Typing methods.
His work carried out in the field of Bordetella pertussis brings together such families of science as Whooping cough and Pertactin.
His Serotype study combines topics from a wide range of disciplines, such as Legionella and Molecular epidemiology.
His most cited work include:
- Guidelines for the validation and application of typing methods for use in bacterial epidemiology (611 citations)
- Effectiveness of maternal pertussis vaccination in England: an observational study (453 citations)
- Consensus sequence-based scheme for epidemiological typing of clinical and environmental isolates of Legionella pneumophila (275 citations)
What are the main themes of his work throughout his whole career to date?
Norman K. Fry spends much of his time researching Microbiology, Serotype, Virology, Bordetella pertussis and Pediatrics.
His research in Microbiology is mostly concerned with Typing.
His biological study spans a wide range of topics, including Pneumococcal conjugate vaccine, Streptococcus pneumoniae, Pneumococcal disease, Antigen and Internal medicine.
Norman K. Fry works mostly in the field of Virology, limiting it down to topics relating to Immunoassay and, in certain cases, Multiplex.
His Bordetella pertussis study also includes fields such as
-
Whooping cough and related Pertussis vaccine and Serology,
-
Pertactin which is related to area like Virulence,
-
Pulsed-field gel electrophoresis which intersects with area such as Allele.
His Pediatrics study also includes
-
Vaccination together with Outbreak and Cohort,
-
Incidence that intertwine with fields like Epidemiology.
He most often published in these fields:
- Microbiology (30.72%)
- Serotype (25.30%)
- Virology (21.69%)
What were the highlights of his more recent work (between 2017-2021)?
- Serotype (25.30%)
- Incidence (10.84%)
- Streptococcus pneumoniae (13.86%)
In recent papers he was focusing on the following fields of study:
Norman K. Fry mainly focuses on Serotype, Incidence, Streptococcus pneumoniae, Pneumococcal conjugate vaccine and Pediatrics.
His Serotype study improves the overall literature in Microbiology.
The study incorporates disciplines such as Epidemiology, Disease, Invasive disease, Public health and Pneumococcal infections in addition to Incidence.
His Streptococcus pneumoniae study integrates concerns from other disciplines, such as Odds ratio, Antigen and Virology.
His Pneumococcal conjugate vaccine research incorporates elements of Cohort study and Pneumonia.
His Pediatrics research is multidisciplinary, incorporating elements of Toxigenic Corynebacterium diphtheriae, Survival analysis, Contact tracing and Vaccination.
Between 2017 and 2021, his most popular works were:
- Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study (205 citations)
- Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination (52 citations)
- Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England. (49 citations)
In his most recent research, the most cited papers focused on:
- Bacteria
- Internal medicine
- Gene
Norman K. Fry mostly deals with Serotype, Pneumococcal conjugate vaccine, Incidence, Pneumococcal disease and Pediatrics.
Serotype is a subfield of Microbiology that he tackles.
His Pneumococcal conjugate vaccine research integrates issues from Carriage and Internal medicine.
His studies deal with areas such as Epidemiology, Pneumococcal infections and Vaccination as well as Incidence.
His Vaccination research is multidisciplinary, relying on both Pneumococcal conjugate vaccination and Cohort.
Pediatrics and Public health are frequently intertwined in his study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
